Table 2.
Clinical Outcomes
| Clinical outcomes | All (n = 34) | Died (n = 15) | Discharged alive (n = 9) | Signed off (n = 10) |
|---|---|---|---|---|
| Palliative care visit frequency, median (IQR) | 4.5 (6) | 3 (7.0) | 5 (7.0) | 6.5 (6.3) |
| Use of videoconference, n (%) | 8 (23.5) | 3 (20.0) | 3 (33.3) | 2 (20.0) |
| Duration of follow-up, days, median (IQR) | 11 (17) | 5 (7.5) | 13 (27) | 18 (11) |
| Use of multidisciplinary support, n (%) | 10 (29.4) | 10 (66.7) | 1 (11.1) | 5 (50) |
| Code status changed, n (%) | 15 (44.1) | 12 (80.0) | 2 (22.2) | 1 (10) |
| LST at the end of follow-up, n (%) | ||||
| Mechanical ventilation | 11 (32.4) | 5 (33.3) | 3 (33.3) | 3 (30) |
| Renal replacement therapy | 2 (5.9) | 2 (13.3) | 0 (0) | 2 (20) |
| Vasopressors | 4 (11.8) | 4 (26.7) | 0 (0) | 1 (10) |
| Withdrawal of LSTs, n (%) | 8 (23.5) | 8 (53.3) | 0 (0) | 0 (0) |
LST, life-sustaining treatment.